Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Src I1

Inhibitor of Src kinase and p56lck tyrosine kinase
 
BML-EI398-0025 25 mg 312.00 USD
Do you need bulk/larger quantities?
 
Potent, dual site (ATP domain and substrate-binding domain) Src and Lck kinase inhibitor (IC50=44 and 88nM respectively). VEGFR2 IC50=0.32μM; c-fms IC50=30μM.

Product Specification

Alternative Name:6,7-Dimethoxy-N-(4-phenoxyphenyl)-4-quinazolinamine
 
Formula:C22H19N3O3
 
MW:373.4
 
CAS:179248-59-0
 
Purity:≥98% (HPLC)
 
Appearance:Off-white solid.
 
Solubility:Soluble in DMSO (5mg/ml).
 
Shipping:Ambient
 
Long Term Storage:Ambient
 
Use/Stability:Store, as supplied, at room temperature for up to 1 year. Store solutions at -20°C for up to 3 months.
 
bml-ei398
Please mouse over
bml-ei398

Product Literature References

c-Src tyrosine kinase mediates high glucose-induced endothelin-1 expression: S.A. Manea, et al.; Int. J. Biochem. Cell Biol. 75, 123 (2016), Application(s): Cell culture, Abstract;
The selectivity of protein kinase inhibitors: a further update: J. Bain, et al.; Biochem. J. 408, 297 (2007), Abstract;
Structural determinants for potent, selective dual site inhibition of human pp60c-src by 4-anilinoquinazolines: G. Tian, et al.; Biochemistry 40, 7084 (2001), Abstract;

Related Literature

Brochures
Integrated solutions for screening Wnt regulators
Integrated solutions for screening Wnt regulators
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,